Information on IMD17

Basic details

Name: Immunodeficiency 17 | Acronym: IMD17
Alt. names:

Gene: CD3G | MOI: Autosomal recessive | Mechanism of action:

No. of cases in DB: 0 | First reported in: 1992

Last updated on: 2023-02-28 16:41:18 by

OMIM: 615607

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial. Refs. PMIDs: 1709425; 1635567

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

0 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Infantile onsetarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
2 Anoperineal fistulaarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
3 Chronic decreased cirulating IgG2arrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
4 Chronic diarrheaarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
5 Oral candidiasisarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
6 Recurrent otitis mediaarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
7 Recurrent respiratory infectionsarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
8 Reduced T cell countarrow icon 2 (99.9%) 0 (0.0%) 0 (0.0%)
9 Autoimmune hemolytic anemiaarrow icon 1 (50.0%) 0 (0.0%) 1 (50.0%)
10 Death in childhoodarrow icon 1 (50.0%) 0 (0.0%) 1 (50.0%)
11 Death in infancyarrow icon 1 (50.0%) 0 (0.0%) 1 (50.0%)
12 Failure to thrivearrow icon 1 (50.0%) 0 (0.0%) 1 (50.0%)
13 Abnormal B cell morphologyarrow icon 0 (0.0%) 0 (0.0%) 2 (99.9%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.